SAA1 and COVID-19: Indeed, current data support the possibility that glial SAA contributes to a non-Aβ CAA and the long-lasting neurological changes from COVID-19; see Figure 1C. Astrocytes, stimulated by IL-6, produce SAA, which, in turn, in the presence of SARS-CoV-2, could produce amyloid deposits [50].